Article Details

GT Biopharma Announces Preclinical Results For Its ROR1 TriKE™ As A Treatment For Prostate ...

Retrieved on: 2021-03-08 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma Announces Preclinical Results For Its ROR1 TriKE™ As A Treatment For Prostate .... View article details on HISWAI: https://www.prnewswire.com/news-releases/gt-biopharma-announces-preclinical-results-for-its-ror1-trike-as-a-treatment-for-prostate-cancer-301242002.html

Excerpt

BEVERLY HILLS, Calif., March 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up